Tools

LEADER 03010nam 2200541 i 4500

001 on1343956137;

003 OCoLC;

005 20220908131725.0;

006 m o d f ;

007 cr |||||||||||;

008 220908s2022 dcua ob f000 0 eng c;

024 8 a| 43-881q| (GPO jacket number);

035 a| (Sirsi) o1343956137;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:116-76;

088 a| Serial no. 116-76 (United States. Congress. House. Committee on Energy and Commerce);

245 10 a| Safeguarding pharmaceutical supply chains in a global economy :b| hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2022.;

300 a| 1 online resource (vi, 176 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| Access ID (govinfo): CHRG-116hhrg43881.;

500 a| "Serial no. 116-76.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services; Michael R. Wessel, Commissioner, U.S.-China Economic and Security Review Commission; Rosemary Gibson, Senior Advisor, The Hastings Center; Edward Price, President and Chief Executive Officer, Seqens N.A; David Gaugh, R.Ph., Senior Vice President, Sciences and Regulatory Affairs, Association for Accessible Medicines.;

518 a| Date of hearing: 2019-10-30.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed Sep. 8, 2022).;

650 0 a| Prescription pricingx| Government policyz| United States.=| ^A63214;

650 0 a| Drugsx| Pricesz| United States.=| ^A30023;

650 0 a| Drugsz| United Statesx| Cost control.=| ^A640;

650 0 a| Drugsx| Law and legislationz| United States.=| ^A639;

650 0 a| Pharmaceutical industryz| United States.=| ^A638;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Print version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.t| Safeguarding pharmaceutical supply chains in a global economyw| (OCoLC)1343956054;

856 40 u| https://purl.fdlp.gov/GPO/gpo1864727| 0;

922 a| GOVINFOHRG;

922 a| BIBCONEWb| 20220908;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5928669;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5928669-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 10/14/2022x| EDOCUMENTz| JERESOURCE;

Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2022.
Description	1 online resource (vi, 176 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo186472
Subjects	Prescription pricing--Government policy. --United States. Drugs--Prices. --United States. Drugs--United States. --Cost control. Drugs--Law and legislation. --United States. Pharmaceutical industry--United States.

General note	Access ID (govinfo): CHRG-116hhrg43881.
General note	"Serial no. 116-76."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services; Michael R. Wessel, Commissioner, U.S.-China Economic and Security Review Commission; Rosemary Gibson, Senior Advisor, The Hastings Center; Edward Price, President and Chief Executive Officer, Seqens N.A; David Gaugh, R.Ph., Senior Vice President, Sciences and Regulatory Affairs, Association for Accessible Medicines.
Date/time/place of a event note	Date of hearing: 2019-10-30.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed Sep. 8, 2022).
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Safeguarding pharmaceutical supply chains in a global economy
Genre/form	Legislative hearings.
Standard identifier#	43-881 (GPO jacket number)
Technical rpt number	Serial no. 116-76 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:116-76

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.

Click here for more information about this title

Availability